Order Article Reprints

Salminen L, Braicu EI, Lääperi M, Jylhä A, Oksa S, Hietanen S, Sehouli J, Kulbe H, Bois Ad, Mahner S, et al. A Novel Two-Lipid Signature Is a Strong and Independent Prognostic Factor in Ovarian Cancer. Cancers. 2021; 13(8):1764. https://doi.org/10.3390/cancers13081764

Salminen, Liina, Elena Ioana Braicu, Mitja Lääperi, Antti Jylhä, Sinikka Oksa, Sakari Hietanen, Jalid Sehouli, Hagen Kulbe, Andreas du Bois, Sven Mahner, and et al. 2021. "A Novel Two-Lipid Signature Is a Strong and Independent Prognostic Factor in Ovarian Cancer" Cancers 13, no. 8: 1764. https://doi.org/10.3390/cancers13081764

Salminen, L., Braicu, E. I., Lääperi, M., Jylhä, A., Oksa, S., Hietanen, S., Sehouli, J., Kulbe, H., Bois, A. d., Mahner, S., Harter, P., Carpén, O., Huhtinen, K., Hynninen, J., & Hilvo, M. (2021). A Novel Two-Lipid Signature Is a Strong and Independent Prognostic Factor in Ovarian Cancer. Cancers, 13(8), 1764. https://doi.org/10.3390/cancers13081764